Biden’s Covid Plan is Trump’s Plan

 

(This post was first posted on 8/31/20.)

(Note: In these last few days before the presidential election, I am reposting earlier posts that concern key issues in the election. In Biden television ads he claims he would have done a better job of protecting the country from Covid. But when the Biden plan was released in August, analysts pointed out the Biden plan is exactly what Trump did!)

 

The long-awaited plan of Joe Biden to solve our Covid-19 pandemic is finally over. In his acceptance speech for the Democratic presidential nomination he revealed his plan – it’s what Trump is already doing!

Despite months of criticism of Trump’s handling of the virus by Biden and every other Democratic leader, they couldn’t come up with anything better. The Wall Street Journal editorial board says, “The Democratic nominee is also promising a better virus strategy, which would be wonderful if he had one. But the virus plan he’s pushing is little different on the substance than what the Trump Administration is already doing.”

Let’s look at each step in the Biden Covid-19 plan:

  • Virus Testing – Biden promises to “develop and deploy rapid tests with results available immediately.” The Food and Drug Administration (FDA) in the past week has approved two new rapid tests that can be scaled up quickly. After an initial delay in testing caused by errors at the Centers for Disease Control and Prevention (CDC) and FDA, supply-chain delays have been worked out. The U.S. is now conducting 700,000 tests or more per day, up from 400,000 in early June and 100,000 in late March. The cheap saliva tests developed by Yale researchers will avoid chemical reagent shortages and can cost as little as $10.

 

  • More PPE, Test kits, and Lab supplies – Biden is calling for “a coordinated, country-wide, future-facing national effort to acquire, produce, and distribute PPE, test kits, and machines, lab supplies, and other critical supplies, including by fully utilizing the authorities” under the Defense Production Act. The Trump Administration is already doing all of this. In the hospital and surgery center where I work, there has never been a shortage of these supplies.

 

The Trump administration has effectively used public-private partnerships to rally the “arsenal of democracy” (the private sector) to produce the needed supplies for this pandemic. The Pentagon this spring issued $259 million in contracts to 3M, Honeywell, and Owens & Minor to produce tens of millions of N95 face masks for medical workers. U.S. companies like GM and New Balance have retrofitted plants to produce ventilators and PPE, and the Administration has used the Defense Production Act to allocate more tests and protective equipment to hot spots.

 

  • Hire Federal Contact Workers – Biden has called for hiring 100,000 federal workers to track down contacts of people who get sick. States are already doing this, though public health officials say contact tracing is of little use when the virus is widespread in communities. California tried this approach this summer, training 10,000 contact tracers. But the Sacramento Bee last month reported most never were assigned work for inexplicable reasons.

 

  • Increase vaccine production – Biden promises to “ramp up the large-scale manufacturing of as many vaccine candidates as necessary.” I guess he hasn’t been listening to the news from his Delaware basement. The Trump Administration and private industry are already on that. (Vaccine Progress Due to Planning)

 

Health and Human Services this spring issued a $628 million contract to Emergent BioSolutions, a private firm, to coordinate with vaccine developers ramping up manufacturing capacity. The Administration has contracted with Johnson & Johnson, Pfizer, BioNTech, Moderna, and AstraZeneca for hundreds of millions of dosages as soon as their vaccines are proven safe and effective in trials. Pfizer and BioNTeach recently announced their vaccine is on track to seek regulatory approval as early as October.

The National Institutes of Health (NIH) is also funding promising treatments. Last month the Trump Administration signed a contract with Regeneron to manufacture 300,000 doses of its antibody cocktail by the end of the summer. On the other hand, Biden has proposed price controls and threats of prosecution of health-care executives. These measures would surely dampen the incentive to develop therapies and vaccines as soon as possible.

 

  • Money for Schools to Reopen – Biden says he’ll give schools “the resources they need to be open, safe, and effective.” President Trump has said the same thing – if they reopen. Biden’s support for teachers unions threatens the ability of schools to reopen regardless of the federal financial support.

 

  • National Mask Mandate – Biden also says he’ll impose a national mask mandate. Trump has encouraged masks in public, but left the decision up to the state governors. The Constitution doesn’t give the federal government the authority to mandate masks on a national level. That authority is left to the states.

 

There you have it, the Biden plan revealed. If you were looking for something exciting and different, you will be very disappointed. The Trump Administration is already way ahead of Biden and has implemented everything in his plan – except a national mask mandate. I guess Uncle Joe isn’t familiar with the Constitution.

 

Epidemiologists Reject Political Correctness

 

It takes a lot of courage to be politically incorrect. That’s especially true in this era of the Covid-19 pandemic. Fortunately, there are some individuals willing to take the heat.

Two of those are Jay Bhattacharya and Martin Kulldorff.  Dr. Bhattacharya is a physician and economist at Stanford Medical School and Mr. Kulldorff is a biostatistician at Harvard Medical School. They both study epidemiology at these highly respected medical institutions. Though they work thousands of miles apart, they have come to regard each other so closely they believe they could complete each other’s sentences.

They come from widely different backgrounds. Bhattacharya is from Kolkata, India, while Kulldorff is from Umea, Sweden. What brings them together is their agreement on the best means of handling this Covid-19 pandemic. They are the authors, along with Sunetra Gupta, a professor of epidemiology at Oxford, of the Great Barrington Declaration.

Tunku Varadarajan interviewed them for The Wall Street Journal. Big Tech has tried to censor this information by burying it in any Google search, much like Facebook and Twitter have done with the Hunter Biden laptop story. Hopefully you can read this interview yourself, but this post will give you a preview of their important work.

The Great Barrington Declaration is described as a “cri de coeur against lockdowns and other economic restrictions that have hobbled swaths of the world. It asks instead for “focused protection” – a policy of allowing “those at minimal risk of death” to resume their lives while societies concentrate on “better protecting those who are at highest risk.”

“The politicization of Covid,” Mr. Kulldorff says, “is extremely unfortunate. People automatically assume what your political beliefs are based on your views on the pandemic. This is very strange, in my mind.” Dr. Bhattacharya adds that “the traditional markers for political identity have absolutely no meaning” in the context of Covid. While Bhattacharya admits he leans center-right, Kulldorff refuses to characterize his politics, but Bhattacharya reveals Covid has taught him that he shares values “with people with very, very different political stripes than me. Martin is certainly a great example of this, probably the prime example.”

But when it comes to “current Covid policy”, the two are united. Bhattacharya describes this policy “violates every single value I hold dear, every single one.” He describes these values as “the protection of the vulnerable and the poor world-wide from avoidable death and suffering.” He says “the lockdowns have manifestly failed to do this by inducing economic collapse that has placed the lives of 130 million poor people world-wide at risk of starvation.”

He also cites “the norms of medical ethics that militate against doing harm to patients.” He states the current lockdown policy asks children and young adults – “who face more medical and psychological risk from the lockdowns than they do from Covid infection” – to accept this harm “in the false hope that this sacrifice will protect the vulnerable people.”

Mr. Kulldorff describes lockdowns as “the worst assault on the working class in half a century – the worst assault since segregation and the Vietnam War.” He says “present policies are protecting very low risk professionals – attorneys, bankers, journalists, scientists, because basically we can work from home.” In contrast to privileged professionals, Mr. Kulldorff says, the blue-collar class is “out there working, including high-risk people in their 60s. So the working class is building up the population immunity that will eventually protect all of us.” This explains why minority populations have had higher mortality in the U.S. from the epidemic because they don’t often have the option to stay at home.

Mr. Kulldorff says the Covid-19 restrictions violate two cardinal principles of public health:

  • First – “You can’t just look at Covid, you have to look holistically at health and consider the collateral damage.”This damage includes a worsening incidence of cardiovascular disease and cancer and an alarming decline in immunization. People have been avoiding regular doctor visits that normally would treat these conditions. In India, Bhattacharya says tuberculosis programs have been suspended and malaria eradication programs elsewhere.
  • Second – “You can’t just look short-term.” The health harms from these lockdowns will be counted for a very long time. These lockdowns are sewing the seeds of other epidemics: Dr. Bhattacharya says, “Pertussis – whooping cough – will come back. Polio will come back because of the cessation of vaccination campaigns. All these diseases that we’ve made substantial progress in will start to come back.”

 

Both men say their declaration is nothing really new – it’s just a call to return to traditional public health practices. They say the declaration also reflects “the norms of open scientific discourse, which have been violated by proponents of the Covid lockdowns in the name of protecting the public from ‘dangerous ideas.’”

This leads to a discussion of the term “herd immunity”, which Kulldorff calls “the most misunderstood term of 2020.” He says the term can invite “accusations of mass murder” by those who are misusing it. He defines it as “the end state of any epidemic where some immunity actually happens after infection. It’s a biological fact. It’s not something nefarious or strange.” It is not a strategy, as some in the media have suggested and criticized. It is the inevitable end-stage of any pandemic regardless of how it is treated.

Dr. Bhattacharya prefers the term “population immunity”  because he believes it better conveys that herd immunity is a basic scientific principle, from which flows the one important question epidemiologists and policy makers need to consider: “How do we get to that end state with the least amount of devastation, the least amount of human misery, the least amount of death?”

In the recent Presidential Debate, Trump favored ending lockdowns and re-opening as much as possible. Biden favored more lockdowns if the scientists he listens to recommend them. Now that you’ve heard what these scientists have to say, whose opinion do you believe is best?

Flu Shot or Not?

(This post originally was posted 12/14/18.)

(Author’s note: As we enter the last few weeks of the presidential campaign, there are several campaign issues which have been previously addressed in this blog. These include Medicare for All, single-payer healthcare, socialism, school choice and others. In the next few weeks I will be re-posting many of my previous posts on these issues as a review for voters. For this limited time I will be posting five days a week instead of the usual twice a week. These earlier posts will be intermingled with new posts on current topics.)

(This re-post is especially timely since the 2020 pandemic has made us all aware of how serious a viral infection can be. It is imperative that everyone get the flu vaccine now to maximize your immunity before the Covid-19 vaccine is available.)

It’s that time of the year again. No, I don’t mean Christmas. I mean that time when we all have to decide whether or not to get a flu shot.

Many people skip the flu shot vaccine because they don’t think they need it – or they don’t think it will be effective. Either way you’re taking a big risk. At the very least you’ll suffer through weeks of flu symptoms that will probably keep you out of work for at least a few days. At worst it could actually be fatal. (My maternal grandmother died in the flu epidemic of 1918.)

As of November 9, the Centers for Disease Control and Prevention (CDC) was reporting moderate flu activity in Georgia, Louisiana and Oklahoma, and low or minimal activity across the remainder of the country. Influenza A (H1N1), influenza A (H3N2), and influenza B viruses are all circulating, with influenza A (H1N1) being the predominant strain so far. The CDC says this one has shown up in 78.3% of samples tested since late September, with H3N2 21.7% and influenza B 13.1%.

The good news is this year’s influenza vaccine contains an A (H1N1) like virus, an A (H3N2) like virus, and a B like virus. The quadrivalent vaccines include these three viruses plus a B 2013 like virus (Yamagata lineage). This means this year’s vaccines are likely to be effective. As of November 9, 159 million doses have already been administered.

Did you get yours?

The CDC says coverage with the flu vaccine among adults was 37.1 percent during the 2017-2018 flu season compared to 43.3 percent the prior year. Coverage was lower in every age group last year but vaccination increased with age from 26.9 percent among adults aged 18 – 49 to 59.6 percent among adults aged 65 and up. Lest you think the flu is innocuous, there were 959,000 hospitalizations and 79,400 deaths last year! Overall effectiveness last year was about 40 percent.

Rachael Zimlich, R.N., writing for Medical Economics, says a new seasonal influenza vaccine aimed at senior patients is moving forward in the clinical trials process after showing early success in offering additional protection to this particularly susceptible population. The new nanoparticle, NanoFlu, has moved forward to Phase 2 clinical trials with 1,375 older adults enrolled to assess dose and formulation of the vaccine before moving onto a Phase 3 study – perhaps in 2019 – to test immunogenicity.

“The low effectiveness of seasonal influenza vaccines, and in particular the A (H3N2) component of the vaccine, during the 2017-2018 season emphasizes the need for a more effective vaccine,” said Gregory M. Glenn, M.D., president of research and development at Novavax, the company developing NanoFlu. “We believe this addresses important public health challenges caused by influenza and offers a significant advantage over current influenza vaccines.”

Influenza is a serious illness and should be taken more seriously than many people do. While current influenza vaccines have had mixed success in preventing illness, there is hope for improvement in the future and no reason to spurn the protection currently being offered. Get your flu shot today!